Delphia (USA)’s Instil Bio TIL Stock Holding History

Delphia (USA)’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,118	Closed	-$108K	–	362
2022 Q3	$108K	Buy	1,118 +165	+17%	+$18.9K	0.12%	239
2022 Q2	$88K	Buy	+953	New	+$135K	0.06%	350

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Delphia (USA)'s TIL Position: Q4 2022 in Review

Delphia (USA) sold out of Instil Bio (TIL) in Q4 2022, closing a stake of 1,118 shares — an estimated $108K sold.

Delphia (USA) first reported a position in TIL in Q2 2022 and held it in 2 quarters. The position peaked at $108K in Q3 2022. 78 funds tracked by Wall St. Rank hold TIL as of Q4 2022.

Delphia (USA) reported no remaining Instil Bio position as of Q4 2022 after selling out during the quarter.
Delphia (USA) sold 1,118 Instil Bio shares in Q4 2022, an estimated $108K.
Delphia (USA) first reported a position in Instil Bio in Q2 2022 and held it in 2 quarters.
Delphia (USA)'s Instil Bio position peaked at $108K in Q3 2022.
78 funds tracked by Wall St. Rank held Instil Bio as of Q4 2022.

Based on Delphia (USA)'s 13F filing for Q4 2022, filed 14 Feb 2023.